Menlo Park, CA, United States of America

Arcutis, Inc.

Calculating rank

USPTO Granted Patents = 6

Trademarks = 2

Forward Citations = 131

Loading Chart...

1 inventor (with patents filed for the assignee):

David W Osborne (6 out of 43 patents)

6 patents: Sort by Forward Citations

1. 10940142 - Inhibition of crystal growth of roflumilast (2021-03-09),

2. 10172841 - Inhibition of crystal growth of roflumilast (2019-01-08),

3. 10105354 - Inhibition of crystal growth of roflumilast (2018-10-23),

4. 9907788 - Inhibition of crystal growth of roflumilast (2018-03-06),

5. 9895359 - Inhibition of crystal growth of roflumilast (2018-02-20),

6. 9884050 - Inhibition of crystal growth of roflumilast (2018-02-06),

Company Overview

Arcutis, Inc. is a biopharmaceutical company focused on developing innovative therapies for dermatological conditions. With a pipeline of potential treatments for psoriasis, eczema, and other skin diseases, Arcutis is committed to improving the lives of patients with chronic skin conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#193 in Menlo Park, CA

#10,583 in California

#45,030 in US

Menlo Park, CA, United States of America

Arcutis, Inc.

Forward Citations = 131

1 inventor:

David W Osborne (6 out of 43 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Arcutis, Inc.. Retrieved from https://idiyas.com/company/arcutis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]